Alzheimers Disease
Lancet 397:1577-1590, Scheltens, P.,et al, 2021
Controversy and Progress in Alzheimers Disease - FDA Approval of Aducanumab
NEJM 385:doi:10.1056/NEJMp2111320, Rabinovici, G.D., 2021
The Prevalence of Lingual-Facial-Buccal Dynkinesias in the Elderly
Neurol 36:1350-1351, D'Alessandro,R.,et al, 1986